연구동향 분석

Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial

Qi Hua Wei Yang Yu-Jie Zhou Yan Fu Jian Qin Shu Qin Xiao-Min Chen Jin-Cheng Guo De-Zhao Wang Hong Zhan Jing Li Jing-Yu He 2017년

논문상세정보
인용/피인용

' Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial' 의 참고문헌

  • Vasodilators in acute heart failure:review of the latest studies
    Levy PD Curr Emerg Hosp Med Rep 2 126-132 [2014]
  • Urapidil, a dual-acting antihypertensive agent: current usage considerations
    Buch J Adv Ther 27 426-443 [2010]
  • Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplantation
    Zink M J Heart Lung Transplant 21 347-353 [2002]
  • Therapeutic effect of urapidil on myocardial perfusion in patients with ST-elevation acute coronary syndrome
    Yao DK Eur J Intern Med 20 152-157 [2009]
  • The role of intravenous vasodilators in acute heart failure management
    Piper S Eur J Heart Fail 16 827-834 [2014]
  • The problem of decompensated heart failure: nomenclature, classification, and risk stratification
    Felker GM Am Heart J 145 2Suppl S18-S25 [2003]
  • The alpha1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study
    Kozàkovà M Am Heart J 147 E6- [2004]
  • Systemic and regional hemodynamic effects of alpha-adrenoceptor blockade in chronic left ventricular dysfunction in the conscious dog
    Carlyle PF Am Heart J 120 619-624 [1990]
  • Review of vasodilators in acute decompensated heart failure: the old and the new
    Carlson MD J Card Fail 19 478-493 [2013]
  • Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature
    Cherney D J Gen Intern Med 17 937-945 [2002]
  • Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review
    Alexander P Am J Emerg Med 33 133-141 [2015]
  • Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations
    Elkayam U J Cardiovasc Pharmacol Ther 9 227-241 [2004]
  • Impact of intravenous nitroglycerin in the management of acute decompensated heart failure
    den Uil CA Curr Heart Fail Rep 12 87-93 [2015]
  • Heart disease and stroke statistics--2015 update: a report from the American Heart Association
    Mozaffarian D Circulation 131 e29-e322 [2015]
  • Effectiveness and safety of prehospital urapidil for hypertensive emergencies
    Alijotas-Reig J Am J Emerg Med 19 130-133 [2001]
  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
    McMurray JJ Eur Heart J 33 1787-1847 [2012]
  • Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study
    Zannad F Eur J Heart Fail 8 697-705 [2006]
  • Chinese guidelines for the diagnosis and treatment of heart failure 2014
    Chinese Society of Cardiology of Chinese Medical Association Zhonghua Xin Xue Guan Bing Za Zhi 42 98-122 [2014]
  • Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
    Adams KF Jr Am Heart J 149 209-216 [2005]
  • Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study
    Jhund PS Eur J Heart Fail 17 809-817 [2015]
  • B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction
    van Veldhuisen DJ J Am Coll Cardiol 61 1498-1506 [2013]
  • Agents with vasodilator properties in acute heart failure:how to design successful trials
    Mebazaa A Eur J Heart Fail 17 652-664 [2015]
  • Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure
    Tebbe U Eur J Clin Pharmacol 35 305-308 [1988]
  • Acute haemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failure
    Wang RY Eur Heart J 5 745-751 [1984]
  • Acute decompensated heart failure: evolving literature and implications for future practice
    Cicci JD Pharmacotherapy 34 373-388 [2014]
  • A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly
    Yang W Am J Med Sci 350 109-115 [2015]
  • 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
    Writing committee members Circulation 128 e240-e327 [2013]
  • 2010 Chinese guidelines for the management of hypertension
    Liu LS Zhonghua Xin Xue Guan Bing Za Zhi 39 579-615 [2011]